RT Journal Article SR Electronic T1 General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.12.21.21268205 DO 10.1101/2021.12.21.21268205 A1 Julio C. Nunes A1 Megan K. Carroll A1 Kenneth W. Mahaffey A1 Robert M. Califf A1 P. Murali Doraiswamy A1 Sarah Short A1 Svati H. Shah A1 Susan Swope A1 Donna Williams A1 Adrian F. Hernandez A1 David S. Hong YR 2021 UL http://medrxiv.org/content/early/2021/12/30/2021.12.21.21268205.abstract AB Background The General Anxiety Disorder-7 (GAD-7) questionnaire is a standard tool used for screening and follow-up of patients with Generalized Anxiety Disorder (GAD). Although it is generally accepted that anxiety correlates with clinical and psychosocial stressors, precise quantitative data is limited on the relations among GAD-7, traditional biomarkers, and other measures of health. Even less is known about how GAD-7 relates to race, ethnicity, and socioeconomic status (SES).We determined how multiple demographic and socioeconomic data correlate with the participants’ GAD-7 results when compared with laboratory, physical function, clinical, and other biological markers.Methods The Project Baseline Health Study (BHS) is a prospective cohort of adults representing several populations in the USA. We analyzed a deeply phenotyped group of 2502 participants from that study. Measures of interest included: clinical markers or history of medical diagnoses; physical function markers including gait, grip strength, balance time, daily steps, and echocardiographic parameters; psychometric measurements; activities of daily living; socioeconomic characteristics; and laboratory results.Results Higher GAD-7 scores were associated with female sex, younger age, and Hispanic ethnicity. Measures of low SES were also associated with higher scores, including unemployment, income ≤$25,000, and ≤12 years of education. After adjustment for 166 demographic, clinical, laboratory, and symptom characteristics, unemployment and overall higher SES risk scores were highly correlated with anxiety scores. Protective factors included Black race and older age.Limitations Correlations identified in this cross-sectional study cannot be used to infer causal relationships; further, we were not able to account for possible use of anxiety treatments by study participants.Conclusions These findings highlight the importance of understanding anxiety as a biopsychosocial entity. Clinicians and provider organizations need to consider both the physical manifestations of the disorder and their patients’ social determinants of health when considering treatment pathways and designing interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Baseline Health Study and this analysis were funded by Verily Life Sciences, South San Francisco, CA. This analysis was funded by Verily Life Sciences (South San Francisco, CA) in partnership with Stanford University and Duke University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Project Baseline Study (NCT03154346) was approved by a central IRB (Western IRB/WCG) and by the IRBs of all participating sites.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Baseline Study data will be available to qualified researchers for exploratory analysis after the data are adequately curated and initial planned primary manuscripts are written. Qualified external researchers will be able to apply through applications reviewed by the Proposal Review and Publications Committee and Scientific Executive Committee.